<DOC>
	<DOCNO>NCT01770899</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness oral montelukast ( Singulair ) give standard asthma medication treatment treatment child status asthmaticus . Status asthmaticus acute asthma attack respond standard intermittent treatment require continuous medication aid breathing . While new medication use well manage chronic asthma , acute asthma exacerbation continue significant cause hospitalization even death child . Oral montelukast safe medication use manage chronic asthma child , study use status asthmaticus . If oral montelukast , give standard therapy , reduce treatment length associate severe , acute asthma exacerbation child , could potentially improve morbidity burden pediatric asthma .</brief_summary>
	<brief_title>Evaluation Montelukast Treatment Status Asthmaticus</brief_title>
	<detailed_description>While new medication use well manage chronic asthma , acute exacerbation continue significant cause pediatric morbidity mortality . Montelukast hold establish role pediatric outpatient management asthma two promising study adults demonstrated potential use adjunctive therapy acute exacerbation , similar use pediatrics yet establish . This pilot study design prospective , double blind , randomize , control , clinical trial comparing use oral montelukast plus standard care vs. standard care alone child admit status asthmaticus pediatric intensive care unit ( PICU ) . The primary outcome investigator interested time reach Modified Pediatric Asthma Score ( PAS ) &lt; 5 , , per clinical protocol treatment status asthmaticus , time patient able come continuous bronchodilator therapy . If oral montelukast , give standard therapy , reduce treatment , emotional , financial burden ( e.g. , shorten intensive care stay ) associate severe , acute asthma exacerbation child , would provide significant therapeutic advantage , potentially improve morbidity burden pediatric asthma .</detailed_description>
	<mesh_term>Status Asthmaticus</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Inclusion criterion : Between age 2148 year Requiring PICU admission status asthmaticus Able take oral medication Pediatric asthma score &gt; 8 admission Exclusion criterion : Intubated patient patient unable take medication mouth secondary anatomic preexist craniofacial issue Patients already montelukast controller medication Patients know allergy montelukast Any patient phenylketonuria ( PKU ) Any patient currently treatment rifampin , fluconazole , Phenobarbital medication</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Montelukast</keyword>
	<keyword>Singulair</keyword>
	<keyword>status asthmaticus</keyword>
</DOC>